Anticoagulant Therapy in Connection With Cardioversion in Patients With Atrial Fibrillation

被引：0
作者：
Furman, N. V. [1 ]
Kuvshinova, L. E. [1 ]
Dovgalevsky, Ya P. [1 ]
机构：
[1] Saratov Res Inst Cardiol, Saratov 410028, Russia
来源：
KARDIOLOGIYA | 2012年 / 52卷 / 09期
关键词：
atrial fibrillation; cardioversion; anticoagulants; DIRECT THROMBIN INHIBITOR; RHYTHM-CONTROL; DABIGATRAN ETEXILATE; COST-EFFECTIVENESS; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULANT; TREATMENT STRATEGY; WARFARIN; STROKE; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We present data on possibility of anticoagulant therapy in conjunction with electrical cardioversion in patients with atrial fibrillation using novel anticoagulant - dabigatran - and a case of successful lysis of thrombus in the left ventricular cavity at the background of its administration.
引用
收藏
页码：69 / 76
页数：8
相关论文
共 63 条
[1]  
Alekseevskaya I.N., 2009, J ARRHYTHMOL, V56, P20
[2]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[3]   Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States [J].
Baker, William L. ;
Cios, Deborah A. ;
Sander, Stephen D. ;
Coleman, Craig I. .
JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (03) :244-252
[4]   Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents [J].
Bassand, Jean-Pierre .
EUROPACE, 2012, 14 (03) :312-324
[5]   Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran [J].
Beasley, B. Nhi ;
Unger, Ellis F. ;
Temple, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1788-1790
[6]   Analysis of direct costs associated with the use of warfarin in patients with atrial fibrillation [J].
Belousov, Yu. B. ;
Yavelov, I. S. ;
Belousov, D. Yu. ;
Afanasieva, E. V. .
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (05) :561-566
[7]  
Belousov YB, 2012, KARDIOLOGIYA, V52, P44
[8]   Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation [J].
Birman-Deych, E ;
Radford, MJ ;
Nilasena, DS ;
Gage, BF .
STROKE, 2006, 37 (04) :1070-1074
[9]   The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans [J].
Blech, Stefan ;
Ebner, Thomas ;
Ludwig-Schwellinger, Eva ;
Stangier, Joachim ;
Roth, Willy .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) :386-399
[10]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
1234567